Fingerprint
Dive into the research topics of 'Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the adalimumab in Canadian subjects with moderate to severe Crohn's diseaSe (ACCESS) trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically